New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 2, 2013
06:43 EDTBCRC.R. Bard upgraded to Overweight from Neutral at JPMorgan
JPMorgan upgraded C.R. Bard based on expectations for a resolution of the Gore patent litigation, a positive outcome in the LEVANT 2 trial, and higher earnings revisions. Price target raised to $116 from $110.
News For BCR From The Last 14 Days
Check below for free stories on BCR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for BCR

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use